ConductScience.org, home

Paper3555331

Acyclovir prophylaxis for herpes simplex virus infection.

Gold D and 1 other. Antimicrob Agents Chemother, 1987. Cited by 80 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Acyclovir prophylaxis for herpes simplex virus infection. Papers, record 3555331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3555331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acyclovir prophylaxis for herpes simplex virus infection.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
3.64
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gold DD
2Corey LL

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcyclovirMajor topic
Herpes SimplexMajor topic
Acquired Immunodeficiency Syndrome
Drug Resistance, Microbial
Humans
Immune Tolerance

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-07044NIAID NIH HHSUnited StatesT32AI007044PubMed and NIHNIH RePORTER
AI-20381NIAID NIH HHSUnited StatesR01AI020381PubMed and NIHNIH RePORTER

Download CSV of grants

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16378236
Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
Br J Cancer1984https://conductscience.org/library/papers/6378236PubMed
26088819Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.JAMA1984https://conductscience.org/library/papers/6088819PubMed
36089636Reactivation of type 2 herpes simplex virus by thoracolumbar neurosurgery.Ann Intern Med1984https://conductscience.org/library/papers/6089636PubMed
46090539Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.J Infect Dis1984https://conductscience.org/library/papers/6090539PubMed
52578707Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study.Acta Derm Venereol1985https://conductscience.org/library/papers/2578707PubMed
63977196Acyclovir and suppression of frequently recurring herpetic whitlow.Ann Intern Med1985https://conductscience.org/library/papers/3977196PubMed
73985514Post-herpetic erythema multiforme prevented with prophylactic oral acyclovir.Ann Intern Med1985https://conductscience.org/library/papers/3985514PubMed
82986508Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.Ann Intern Med1985https://conductscience.org/library/papers/2986508PubMed
92988143Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.Sex Transm Dis1985https://conductscience.org/library/papers/2988143PubMed
102996346Infectious complications in heart-lung transplant recipients.Am J Med1985https://conductscience.org/library/papers/2996346PubMed
112996410Treatment of infections in patients with the acquired immunodeficiency syndrome.Ann Intern Med1985https://conductscience.org/library/papers/2996410PubMed
122997101Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.J Antimicrob Chemother1985https://conductscience.org/library/papers/2997101PubMed
132999455Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.JAMA1985https://conductscience.org/library/papers/2999455PubMed
143512419Acyclovir in first attacks of genital herpes and prevention of recurrences.Genitourin Med1986https://conductscience.org/library/papers/3512419PubMed
153912971Pathways to new drugs.Scand J Infect Dis Suppl1985https://conductscience.org/library/papers/3912971PubMed
163010782Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.Ann Intern Med1986https://conductscience.org/library/papers/3010782PubMed
173012335Acquisition of genital herpes from an asymptomatic sexual partner.N Engl J Med1986https://conductscience.org/library/papers/3012335PubMed
183015019Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes.Antiviral Res1986https://conductscience.org/library/papers/3015019PubMed
1910328018Historical findings in subjects from a high socioeconomic group who have genital infections with herpes simplex virus.Sex Transm Dis1982https://conductscience.org/library/papers/10328018PubMed
2014164964RECURRENT ECZEMA HERPETICUM. WIDESPREAD CUTANEOUS HERPES SIMPLEX IN ATOPIC PATIENT WITHOUT ACTIVE ATOPIC DERMATITIS.Arch Dermatol1964https://conductscience.org/library/papers/14164964PubMed

See all 63 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42639594Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial.Transplant Direct2026https://conductscience.org/library/papers/42639594PubMed
40050867Antiviral treatment for viral pneumonia: current drugs and natural compounds.Virol J2025https://conductscience.org/library/papers/40050867PubMed
38853607Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis.J Infect Dis2024https://conductscience.org/library/papers/38853607PubMed
33857746Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.Leuk Res2021https://conductscience.org/library/papers/33857746PubMed
32910331Ocular surgery after herpes simplex and herpes zoster keratitis.Int Ophthalmol2020https://conductscience.org/library/papers/32910331PubMed
24315793Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1.Antiviral Res2014https://conductscience.org/library/papers/24315793PubMed
21991950Oral acyclovir suppression and neurodevelopment after neonatal herpes.N Engl J Med2011https://conductscience.org/library/papers/21991950PubMed
20645244Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells.Planta Med2011https://conductscience.org/library/papers/20645244PubMed
19341466Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection.BMC Dermatol2009https://conductscience.org/library/papers/19341466PubMed
12034687The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin.Br J Ophthalmol2002https://conductscience.org/library/papers/12034687PubMed
11519289Anti-herpes viruses agents.Indian J Pediatr2001https://conductscience.org/library/papers/11519289PubMed
8383946Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8383946PubMed
3435132Acyclovir prophylaxis for herpes simplex virus infection.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3435132PubMed
3280914Antiviral agents.Med Clin North Am1988https://conductscience.org/library/papers/3280914PubMed
2653790Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.Drugs1989https://conductscience.org/library/papers/2653790PubMed
2550235Persistent herpes simplex virus infection and mechanisms of virus drug resistance.Eur J Clin Microbiol Infect Dis1989https://conductscience.org/library/papers/2550235PubMed
1850439Herpes simplex virus hepatitis after solid organ transplantation in adults.J Infect Dis1991https://conductscience.org/library/papers/1850439PubMed
1377898In vitro toxicological evaluation of ISIS 1082, a phosphorothioate oligonucleotide inhibitor of herpes simplex virus.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1377898PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3555331

GET https://conductscience.org/api/papers/v1/3555331/references?page=2